Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review.

Kremer LC, van der Pal HJ, Offringa M, van Dalen EC, Voûte PA.

Ann Oncol. 2002 Jun;13(6):819-29. Review.

2.

Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review.

Kremer LC, van Dalen EC, Offringa M, Voûte PA.

Ann Oncol. 2002 Apr;13(4):503-12. Review.

3.

Cardiac toxicity after anthracycline chemotherapy in childhood.

Iarussi D, Indolfi P, Galderisi M, Bossone E.

Herz. 2000 Nov;25(7):676-88. Review.

PMID:
11141677
4.

Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review.

Bryant J, Picot J, Levitt G, Sullivan I, Baxter L, Clegg A.

Health Technol Assess. 2007 Jul;11(27):iii, ix-x, 1-84. Review.

5.

Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience.

Krischer JP, Epstein S, Cuthbertson DD, Goorin AM, Epstein ML, Lipshultz SE.

J Clin Oncol. 1997 Apr;15(4):1544-52.

PMID:
9193351
6.

Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up.

Elbl L, Hrstkova H, Tomaskova I, Michalek J.

Support Care Cancer. 2006 Feb;14(2):128-36. Epub 2005 Jul 21.

PMID:
16034614
7.

Detection of anthracycline-induced cardiotoxicity: is there light at the end of the tunnel?

Suter TM, Meier B.

Ann Oncol. 2002 May;13(5):647-9. No abstract available.

8.

Automatic border detection identifies subclinical anthracycline cardiotoxicity in children with malignancy.

Hashimoto I, Ichida F, Miura M, Okabe T, Kanegane H, Uese K, Hamamichi Y, Misaki T, Koizumi S, Miyawaki T.

Circulation. 1999 May 11;99(18):2367-70.

9.

Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML.

Creutzig U, Diekamp S, Zimmermann M, Reinhardt D.

Pediatr Blood Cancer. 2007 Jun 15;48(7):651-62.

PMID:
17183582
10.

Regional cardiac wall motion abnormalities during and shortly after anthracyclines therapy.

Kapusta L, Groot-Loonen J, Thijssen JM, DeGraaf R, Daniëls O.

Med Pediatr Oncol. 2003 Nov;41(5):426-35.

PMID:
14515381
11.

Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults.

Dodos F, Halbsguth T, Erdmann E, Hoppe UC.

Clin Res Cardiol. 2008 May;97(5):318-26. doi: 10.1007/s00392-007-0633-6. Epub 2008 Jan 14.

PMID:
18193371
12.

Early identification of anthracycline cardiomyopathy: possibilities and implications.

Bu'Lock FA, Mott MG, Oakhill A, Martin RP.

Arch Dis Child. 1996 Nov;75(5):416-22.

13.

Cardiac functions by myocardial performance index and QT dispersion in survivors of childhood lymphoblastic leukaemia.

Gulen H, Kazanci E, Mese T, Uzunkaya D, Erbay A, Tavli V, Vergin C.

Minerva Pediatr. 2007 Apr;59(2):107-13.

PMID:
17404560
14.

Cumulative incidence and risk factors of mitoxantrone-induced cardiotoxicity in children: a systematic review.

van Dalen EC, van der Pal HJ, Bakker PJ, Caron HN, Kremer LC.

Eur J Cancer. 2004 Mar;40(5):643-52. Review.

PMID:
15010064
15.

Anthracycline-associated cardiotoxicity in survivors of childhood cancer.

Trachtenberg BH, Landy DC, Franco VI, Henkel JM, Pearson EJ, Miller TL, Lipshultz SE.

Pediatr Cardiol. 2011 Mar;32(3):342-53. doi: 10.1007/s00246-010-9878-3. Epub 2011 Jan 9.

PMID:
21221562
16.

The evaluation of left ventricular function in childhood cancer survivors by pharmacological stress echocardiography.

Elbl L, Hrstkova H, Chaloupka V, Novotny J, Michalek J.

Neoplasma. 2003;50(3):191-7.

PMID:
12937852
18.

Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management.

Iarussi D, Indolfi P, Casale F, Martino V, Di Tullio MT, Calabrò R.

Paediatr Drugs. 2005;7(2):67-76. Review.

PMID:
15871628
19.

Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy.

Pinarli FG, Oğuz A, Tunaoğlu FS, Karadeniz C, Gökçora N, Elbeg S.

Pediatr Blood Cancer. 2005 Apr;44(4):370-7.

PMID:
15602715
20.

[Anthracycline cardiotoxicity].

Finolezzi E, Torromeo C, Vincenzi B, Avvisati G.

Clin Ter. 2003 Mar-Apr;154(2):115-21. Review. Italian.

PMID:
12856371
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk